EUVIMEDSkopri EUVIMED
Kohortenstudie

Post‐colonoscopy cancer rates in Scotland from 2012 to 2018: A population‐based cohort study

Jack Winter iD, Gavin Clark, Robert Steele, Michelle Thornton

Colorectal Disease · 2025

DOI: 10.1111/codi.17298 ↗

At a glance

Kohortenstudie in Colorectal Disease, 2025. Written by Jack Winter and 3 co-authors. Institution: Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK. Major MEDLINE topics: Colonoscopy, Colorectal Neoplasms, Early Detection of Cancer. Cited 3 times so far (Crossref); 25 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aim

The aim of this work was to quantify post‐colonoscopy colorectal cancer (PCCRC) rates in National Health Service (NHS) Scotland using World Endoscopy Association guidelines, compare incidence between health boards and referral streams and explore comparisons in results with published data from other healthcare systems.

Method

This is a population‐based cohort study using NHS Scotland data between 2012 and 2018. All people undergoing colonoscopy between 2012 and 2018 and subsequently diagnosed as having bowel cancer up to 3 years after their investigation were included. The main outcome measures are national trends in the PCCRC rate at 3 years (PCCRC‐3yr). with comparison between bowel screening and non‐screening referral routes, board of referral and analysis of factors associated with occurrence.

Results

The overall unadjusted PCCRC‐3yr was 7.9% (7.4%–8.3%). There was no change in the annual rate over the 7‐year study period. The PCCRC rate was lower for the Scottish Bowel Cancer Screening Programme (6.7% vs. 8.3%), but compared unfavourably with rates reported by the NHS England Bowel Cancer Screening Programme from an earlier time period. There was wide variation in rates between health boards of similar population size. Rates were higher in women, with increasing age and in patients with a history of inflammatory bowel disease or diverticular disease.

Conclusion

Despite advances in technology, there has been no improvement in the PCCRC rate in Scotland between 2012 and 2018. Rates in bowel screening colonoscopy are better than in nonscreening colonoscopy but compare unfavourably with NHS England, possibly as a result of less robust endoscopist selection and training. Quality improvement is required in colonoscopy in order to improve patient outcomes nationally, and to allow equitable access to higher‐quality colonoscopy in different regions of the country.

Subjects

MeSH terms (MEDLINE)

ColonoscopyColorectal NeoplasmsEarly Detection of CancerHumansScotlandFemaleMaleMiddle AgedAgedCohort StudiesIncidenceReferral and ConsultationState MedicineAdult

Author keywords

adenomacolonoscopycolorectal cancerendoscopy qualityscreening

Authors and institutions

  • Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK.
  • Public Health Scotland, UK.
  • Department of Surgery, University of Dundee, Dundee, UK.
  • Department of Surgery, NHS Lanarkshire, Lanarkshire, UK.
  • National Endoscopy Training Programme, Golden Jubilee Hospital, Clydebank, UK.

ORCID profiles: Jack Winter

Cite

APA

Winter, J., Clark, G., Steele, R., & Thornton, M. (2025). Post‐colonoscopy cancer rates in Scotland from 2012 to 2018: A population‐based cohort study. Colorectal Disease. https://doi.org/10.1111/codi.17298

Vancouver

Winter J, Clark G, Steele R, Thornton M. Post‐colonoscopy cancer rates in Scotland from 2012 to 2018: A population‐based cohort study. Colorectal Disease. 2025. doi:10.1111/codi.17298

BibTeX
@article{Winter2025,
  author = {Winter, Jack and Clark, Gavin and Steele, Robert and Thornton, Michelle},
  title = {Post‐colonoscopy cancer rates in Scotland from 2012 to 2018: A population‐based cohort study},
  journal = {Colorectal Disease},
  year = {2025},
  doi = {10.1111/codi.17298}
}
Start for free →